Hemillan, Josephine M.

HRN: 19-37-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2024
CEFUROXIME 1.5GM (VIAL)
03/16/2024
03/19/2024
IV
1.5grams
Q8 X 3 Days
S/P TAHBSO
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: